ŽOURKOVÁ, Alexandra. Effect of mirtazapine and paroxetine on residual symptoms of depressive disorders and their effect on P450 CYP 2D6 activity. Homeostasis. Milano, Italy: C.I.A.N.S., roč. 41, č. 6, s. 242-249, 9 s. ISSN 0960-7560. 2001. |
Další formáty:
BibTeX
LaTeX
RIS
@article{485638, author = {Žourková, Alexandra}, article_location = {Milano, Italy}, article_number = {6}, keywords = {depressive disorder-residual symptoms-CYP 2D6-poor metaboliser-extensive metaboliser}, language = {eng}, issn = {0960-7560}, journal = {Homeostasis}, note = {publ.II.2003}, title = {Effect of mirtazapine and paroxetine on residual symptoms of depressive disorders and their effect on P450 CYP 2D6 activity}, volume = {41}, year = {2001} }
TY - JOUR ID - 485638 AU - Žourková, Alexandra PY - 2001 TI - Effect of mirtazapine and paroxetine on residual symptoms of depressive disorders and their effect on P450 CYP 2D6 activity JF - Homeostasis VL - 41 IS - 6 SP - 242-249 EP - 242-249 PB - C.I.A.N.S. SN - 09607560 N1 - publ.II.2003 KW - depressive disorder-residual symptoms-CYP 2D6-poor metaboliser-extensive metaboliser N2 - The issues related to preventing a relapse of depressive disorder are high on the list of priorities of psychiatry.The achievement of only a partial remission is a predictor of a higher incidence of relapses.30 patients displaying residual symptoms of depressive disorder were treated with paroxetine or mirtazapine in the conditions of a double-blind study involving monitoring CYP 2D6 activity.Both mirtazapine and paroxetine had a positive effect on residual symptoms of depressive disorder. ER -
ŽOURKOVÁ, Alexandra. Effect of mirtazapine and paroxetine on residual symptoms of depressive disorders and their effect on P450 CYP 2D6 activity. \textit{Homeostasis}. Milano, Italy: C.I.A.N.S., roč.~41, č.~6, s.~242-249, 9 s. ISSN~0960-7560. 2001.
|